Hennepin County Medical Center is a Level I adult and pediatric trauma center and safety net hospital in Minneapolis, Minnesota, the county seat of Hennepin County.

There are 484 beds in HCMC.

During the past decade, HCMC conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HCMC" #1 sponsor was "Ajay Israni" with 1 trials, followed by "Angion Biomedica Corp" with 1 trials sponsored, "Hennepin Healthcare Research Institute" with 1 trials sponsored, "Penumbra Inc." with 1 trials sponsored and "Stanford University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HCMC" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "Nucleus Network Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "HCMC" are "COVID-19" (1 trials), "Chronic Liver Disease" (1 trials), "Hemodialysis" (1 trials), "Intracranial Aneurysm" (1 trials) and "Kidney Transplant" (1 trials). Many other conditions were trialed in "HCMC" in a lesser frequency.

Most popular intervention types in "HCMC" are "Other" (3 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ANG-3777" (1 trials), "Penumbra Coil 400TM (PC400), Penumbra Occlusion DeviceTM(POD)" (1 trials), "Penumbra Smart Coil" (1 trials), "Prospective Chart Review" (1 trials) and "collection of body microbioma" (1 trials). Other intervention names were less common.

The vast majority of trials in "HCMC" are 5 trials for "All" genders.

Currently, there are NaN active trials in "HCMC". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in HCMC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in HCMC, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".